FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 119 filers reported holding FATE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $34,000 | +17.2% | 857 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $29,000 | +70.6% | 857 | +13.2% | 0.00% | +33.3% |
| Q1 2020 | $17,000 | +13.3% | 757 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $15,000 | +36.4% | 757 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $11,000 | -26.7% | 757 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $15,000 | +15.4% | 757 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $13,000 | +44.4% | 757 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $9,000 | -25.0% | 757 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $12,000 | +50.0% | 757 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $8,000 | – | 757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |